Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01268189 · ClinicalTrials.gov registry record · NA
Evaluation of Oxygen Diffusion Dressing for Accelerating Healing of Donor Site and Other Wounds
A NA study, sponsored by United States Army Institute of Surgical Research.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01268189: Completed NA study, sponsored by United States Army Institute of Surgical Research.
NCT01268189 is a NA study that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01268189, a NA study, has completed, sponsored by United States Army Institute of Surgical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a single-center, prospective, randomized, and controlled study to evaluate the effectiveness of OxyBand Dressing for the use as a dressing for autogenous skin donor sites compared to our current standard donor site dressing (Xeroform). Hypothesis is that the mean healing time for wounds treated with the OxyBand dressing will be less than the mean healing time for wounds treated with the Xeroform dressing.
Primary Outcome
Wounds are inspected on postoperative days 4, 8, and then every two days until the wound is deemed to be healed.
Interventions
- DEVICE Oxygen diffusing dressing
- DEVICE Standard of care dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT01268189 record still lists
NCT01268189 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Oxygen diffusing dressing is the first listed.
NCT01268189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01268189 about?
NCT01268189 is a clinical study titled "Evaluation of Oxygen Diffusion Dressing for Accelerating Healing of Donor Site and Other Wounds". This is a single-center, prospective, randomized, and controlled study to evaluate the effectiveness of OxyBand Dressing for the use as a dressing for autogenous skin donor sites compared to our current standard donor site dressing (Xeroform). Hypothesis is that the mean healing time for wounds trea...
What is the current status of trial NCT01268189?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01268189?
The interventions under investigation include: Oxygen diffusing dressing (DEVICE), Standard of care dressing (DEVICE).
Who is sponsoring clinical trial NCT01268189?
This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01268189's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia